-
Speakers will dispel myths about muscle and energy expenditure
Lara Dugas, PhD, MPH, and other panelists will examine the impact of common misconceptions and summarize new insights about the dynamics of muscle mass, energy expenditure, and individual metabolism.
-
Panel to explain why smarter is better in pediatric diabetes
Pediatric endocrinologist and physician-scientist Mustafa Tosur, MD, FAAP, will open a symposium on trending topics and smart solutions for diagnosing and managing diabetes in children, adolescents, and young adults.
-
Experts to present new approaches to lower triglycerides, pancreatitis risk
Panelists, including Savitha Subramanian, MD, will detail the latest therapies for severe hypertriglyceridemia, the genetics of hypertriglyceridemia, and the dynamics of hypertriglyceridemia-induced acute pancreatitis
-
PATHWEIGH demonstrates significant weight loss for primary care model
Speakers shared evidence of population-wide weight loss and improved use of weight-related treatment. Mark Gritz, PhD, said the goal was affordable care delivery that could be implemented broadly.
-
2025 Outstanding Educator in Diabetes Award honoree focuses on nutrition
Alison Evert, MS, RDN, CDCES, discussed three key components of diabetes nutrition therapy in her award lecture: research, recommendations, and real-world experiences.
-
Symposium features promise of non-peptide GLP-1 RAs and first report of phase 3 ACHIEVE-1
Julio Rosenstock, MD, shared data from ACHIEVE-1 that show orforglipron led to reductions in A1C and meaningful weight loss as monotherapy in drug-naïve type 2 diabetes with inadequate glycemic management.
-
Celebrity advocate promotes awareness for diabetes in session where ADA President, Health Care & Education touts multidisciplinary approach to care
Actor and diabetes advocate Anthony Anderson had a sit-down conversation with American Diabetes Association® (ADA) Chief Executive Officer Charles “Chuck” Henderson in which he told his own diabetes story during a Saturday session that included the ADA President, Health Care & Education Address.
-
Session will explore analytical tools and use of CGM data to deliver precision diabetes care
Artificial intelligence and machine learning are helping advance personalized medicine. Michael Snyder, PhD, will discuss how continuous glucose monitoring data is transforming diabetes subtyping and management.
-
Experts to give update on GLP-1 RAs and SGLT2i as adjuncts to automated insulin delivery
Viral N. Shah, MD, and Anders L. Carlson, MD, will discuss off-label use of these agents in the type 1 diabetes population. The drugs can lower the insulin requirement to optimize automated insulin delivery and may also reduce cardiovascular risk.
-
Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award debuts
A leading scholar in epidemiology and health equity, Tiffany L. Gary-Webb, PhD, MHS, will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award.